mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.09 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.057 |
0.09 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.094 |
0.1 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.1 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.1 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.069 |
0.1 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.1 |